Cargando…
免疫检查点抑制剂相关心肌炎的研究进展
Immune checkpoint inhibitors (ICIs) is a negative regulatory factor antibody, which activates T cells to play an anti-tumor effect in immunotherapy, and can also cause immune-related adverse responses, thereby inducing a series of immune related adverse events (irAEs). Among these irAEs, although th...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503978/ https://www.ncbi.nlm.nih.gov/pubmed/34521189 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.27 |